Foundation Medicine

Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company's clinical assays, FoundationOne for solid tumors and FoundationOne Heme for hematologic malignancies and sarcomas, provide a comprehensive genomic profile to identify the molecular alterations in a patient's cancer and match them with relevant targeted therapies and clinical trials. Foundation Medicine's molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer.
Type
Public
HQ
Cambridge, US
Founded
2010
Employees
417 (est)+51%

Key People at Foundation Medicine

Kevin Krenitsky

Kevin Krenitsky

Chief Commercial Officer & SVP, International Strategy
Ronald Collette

Ronald Collette

CIO
Alexis Borisy

Alexis Borisy

Co - Founder & Chairman of the Board
Vincent A. Miller

Vincent A. Miller

SVP, Clinical Development
Michael J. Pellini

Michael J. Pellini

President & CEO & Board Director
Steven J. Kafka

Steven J. Kafka

Chief Business Officer

Foundation Medicine Locations

Cambridge, US

Foundation Medicine Metrics

Foundation Medicine Summary

Founding Date

2010

Market capitalization

$682 M

Closing share price

$19.6

Foundation Medicine Market Value History

Foundation Medicine Online Presence

Foundation Medicine News

Foundation Medicine Company Life

You may also be interested in